论文部分内容阅读
目前国内临床治疗的胃癌患者大部分属于进展期,早期胃癌患者相对较少。进展期胃癌手术切除率低,总体预后差。进展期胃癌行新辅助化疗后可以延长生存期,改善生存质量,提高根治性手术切除率,且经介入途径行新辅助化疗,相比较其他化疗方式,具有较好的疗效和较低的毒副反应。本文对当前研究情况加以综述来说明术前介入化疗是一种切实可行有效的进展期胃癌的治疗手段。
At present, most of the clinical treatment of gastric cancer patients are advanced, relatively few patients with early gastric cancer. The surgical resection rate of advanced gastric cancer is low, the overall prognosis is poor. Neoadjuvant chemotherapy in advanced gastric cancer can prolong survival, improve quality of life and improve the rate of radical resection, and neoadjuvant chemotherapy through the interventional route, compared with other chemotherapy, has good efficacy and low toxicity reaction. This article summarizes the current research to illustrate preoperative interventional chemotherapy is a practical and effective treatment of advanced gastric cancer.